Rachael Dickman

ORCID: 0000-0003-3139-5423
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Natural product bioactivities and synthesis
  • Chemical Synthesis and Analysis
  • Analytical Chemistry and Chromatography
  • Glycosylation and Glycoproteins Research
  • Tuberculosis Research and Epidemiology
  • Carbohydrate Chemistry and Synthesis
  • Cancer therapeutics and mechanisms
  • Antimicrobial Peptides and Activities
  • Nerve injury and regeneration
  • Crystallization and Solubility Studies
  • Advanced Chemical Sensor Technologies
  • Biochemical Analysis and Sensing Techniques
  • X-ray Diffraction in Crystallography
  • Biochemical and Structural Characterization
  • Pancreatic function and diabetes
  • Mesenchymal stem cell research
  • Lung Cancer Treatments and Mutations
  • Neurogenesis and neuroplasticity mechanisms
  • Metabolomics and Mass Spectrometry Studies
  • Pneumonia and Respiratory Infections
  • Mycobacterium research and diagnosis
  • Antibiotic Resistance in Bacteria
  • Venomous Animal Envenomation and Studies
  • Plant-based Medicinal Research
  • Phytochemistry and Biological Activities

University College London
2017-2025

University of London
2022

Spider venom toxins, such as Protoxin-II (ProTx-II), have recently received much attention selective Nav1.7 channel blockers, with potential to be developed leads for the treatment of chronic nocioceptive pain. ProTx-II is a 30-amino acid peptide three disulfide bonds that has been reported adopt well-defined inhibitory cystine knot (ICK) scaffold structure. Potential drawbacks peptides include poor pharmacodynamics and scrambling in vivo. In order address these issues, present study we...

10.1021/jacs.7b06506 article EN cc-by Journal of the American Chemical Society 2017-09-07

Parkinson’s disease is a neurodegenerative condition associated with the progressive loss of dopaminergic neurons. This leads to neurological impairments heightening severity and globally increasing in prevalence due to...

10.1039/d4bm01566e article EN cc-by Biomaterials Science 2025-01-01

In response to the growing threat posed by antibiotic-resistant bacterial strains, extensive research is currently focused on developing antimicrobial agents that target lipid II, a vital precursor in biosynthesis of cell walls. The lantibiotic nisin and related peptides display unique highly selective binding II. A key feature nisin–lipid II interaction formation cage-like complex between pyrophosphate moiety two thioether-bridged rings, rings B, at N-terminus nisin. To understand important...

10.1021/acs.joc.9b01253 article EN cc-by The Journal of Organic Chemistry 2019-08-29

In this study, we have designed and synthesized pyrazoline analogues that partially mimic the structure of mycobactin, to address requirement novel therapeutics tackle emerging global challenge antimicrobial resistance (AMR). Our investigation resulted in identification lead compounds 44 49 as potential mycobactin biosynthesis inhibitors against mycobacteria. Moreover, candidates efficiently eradicated intracellularly surviving Thermofluorimetric analysis molecular dynamics simulations...

10.1021/acs.jmedchem.1c01349 article EN Journal of Medicinal Chemistry 2022-01-04

Abstract Natural products that target lipid II, such as the lantibiotic nisin, are strategically important in development of new antibacterial agents to combat rise antimicrobial resistance. Understanding structural factors govern highly selective molecular recognition II by N‐terminal region nisin(1–12), is a crucial step exploiting potential compounds. In order elucidate relationships between amino acid sequence and conformation this bicyclic peptide fragment, we have used solid‐phase...

10.1002/chem.201902814 article EN cc-by Chemistry - A European Journal 2019-10-10

New designs of antimicrobial peptides are urgently needed in order to combat the threat posed by recent increase resistance antibiotics. In this paper, we present a new series peptides, based on key structural features lantibiotic nisin. We have simplified structure nisin conjugating lipid II-binding motif at N-terminus cationic and peptoids with known antibacterial action pore-forming properties. Hybrid where hydrophilic PEG4 linker was used, showed good activity against Micrococcus luteus.

10.1016/j.bmc.2018.10.015 article EN cc-by Bioorganic & Medicinal Chemistry 2018-10-20

Identification and validation of novel therapeutic targets is imperative to tackle the rise drug resistance in tuberculosis. An essential Mur ligase-like gene (Rv3712), expected be involved cell-wall peptidoglycan (PG) biogenesis conserved across mycobacteria, including genetically depleted Mycobacterium leprae, was primary focus this study.Biochemical analysis Rv3712 performed using inorganic phosphate release assays. The operon structure identified reverse-transcriptase PCR a...

10.1093/jacamr/dlab028 article EN cc-by JAC-Antimicrobial Resistance 2021-01-18

Class A serine β-lactamases (SBLs) have a conserved non-active site structural domain called the omega loop (Ω-loop), in which glutamic acid residue is believed to be directly involved hydrolysis of β-lactam antibiotics by providing water molecule during catalysis. We aimed design and characterise potential pentapeptides mask function Ω-loop reduce their efficacy, along with potentiating eventually decreasing resistance. Considering sequence as template, group pentapeptide models were...

10.3390/antibiotics12030553 article EN cc-by Antibiotics 2023-03-10

Lipid II recognition: Analogues of the bicyclic N-terminal region lantibiotic nisin, residues 1–12, were synthesised. In order to analyse how this peptide binds its target, pyrophosphate moiety lipid II, NMR ensemble analysis wild-type and one synthetic analogues was carried out. This revealed that two rings are pre-organised an extent for binding group. A high degree flexibility exhibited in central amide bond joining enables switch between “open” structure a “cage” capable pyrophosphate....

10.1002/chem.201903848 article EN Chemistry - A European Journal 2019-10-10
Coming Soon ...